Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B

February 16, 2005 |

Lung Cancer. 2005 Jun;48(3):423-8. Epub 2005 Feb 16. [Link] Kindler HL, Herndon JE, Zhang C, Green MR; Cancer and Leukemia Group B. University of Chicago, 5841 S. Maryland Avenue, MC…

Differentiation of mesothelioma from adenocarcinoma in serous effusions: The role of hyaluronic acid and CD44 localization

February 2, 2005 |

Diagnostic Cytopathology. Volume 32, Issue 3, Pages 145 – 150. Published Online: 2 Feb 2005. [Link] Alaa M. Afify, M.D. 1 *, Robert Stern, M.D. 2, Claire W. Michael, M.D.…

Benign cystic mesothelioma, a rare tumor of the peritoneum

February 1, 2005 |

Magyar Sebeszet. 2005 Feb;58(1):35-7. [Link] Szollosi A, Ferenc C, Pinter T, Erenyi A, Nagy A. Abstract We report the case of a 28-year-old woman, who presented with acute abdominal and…

Pemetrexed in Malignant Pleural Mesothelioma

February 1, 2005 |

Clinical Cancer Research 11, no. 3 (2005): 982-992. [Link] Maitreyee Hazarika, Robert M. White, Jr., Brian P. Booth, Yong-Cheng Wang, Doo Y. Lee Ham, Cheng Yi Liang, Atiqur Rahman, Jogarao…

Pathogenesis of malignant pleural mesothelioma

January 26, 2005 |

Respirology 10, no. 1 (2005): 2-8. [Link] Marie-Claude Jaurand1 and Jocelyne Fleury-Feith1,2 INSERM E0337, Faculty of Medicine, University Paris XII, Creteil Cedex Histology and Biology of Tumours Tenon Hospital, University…

The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050

January 25, 2005 |

British Journal of Cancer. (2005) 92, 587-593. doi:10.1038/sj.bjc.6602307 Published online 25 January 2005. [Link] J T Hodgson1, D M McElvenny1, A J Darnton1, M J Price1 and J Peto2,3 1Epidemiology…

Radiofrequency Ablation of Thoracic Lesions: Part 2, Initial Clinical Experience Technical and Multidisciplinary Considerations in 30 Patients

January 25, 2005 |

American Journal of Roentgenology 184, no 2 (2005): 381-390. [Link] Eric vanSonnenberg1,2, Sridhar Shankar1,2,3, Paul R. Morrison1, Rashmi T. Nair1,2, Stuart G. Silverman1,2, Michael T. Jaklitsch4,5, Franklin Liu1,2,6, Lawrence Cheung1,2,…

Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients

January 24, 2005 |

Lung Cancer. 2005 Jun;48(3):429-34. Epub 2005 Jan 24. [Link] Porta C, Zimatore M, Bonomi L, Imarisio I, Paglino C, Sartore-Bianchi A, Mutti L. Medical Oncology, I.R.C.C.S. San Matteo University Hospital,…

The Effects of Taurolidine, a Novel Antineoplastic Agent, on Human Malignant Mesothelioma

November 15, 2004 |

Clinical Cancer Research Vol. 10, 7655-7661, November 15, 2004 [Link] Linda Nici, Barbara Monfils and Paul Calabresi Department of Medicine, Rhode Island Hospital and Brown University, Providence, Rhode Island Abstract…

Patterns of failure following surgical resection for malignant pleural mesothelioma

November 1, 2004 | Comments Off on Patterns of failure following surgical resection for malignant pleural mesothelioma

Thoracic Surgery Clinics. 2004 Nov;14(4):567-73. [Link] Janne PA, Baldini EH Harvard Medical School, Boston, MA 02115, USA. pjanne@partners.org Abstract The optimum therapeutic strategy for patients with localized malignant mesothelioma continues…

Categories